This is an academic paper aiming to prove the efficacy of using peer support specialists (PSS) in the emergency department (ED) to increase buprenorphine treatment. The use of PSS to facilitate more ED- initiated buprenorphine treatment by identifying appropriate candidates through screening is feasible but requires coordination and planning.
Treatment Resources
- Medications for Opioid Use Disorder
- Recovery coaching
- Advocates / Peers
- Community Coalitions
- Hospitals
- Medical
The Opioid Misuse Resource Map provides a list of interventions at the community level to address the opioid crisis by each state. The list shows a number of opioid-related projects that have been compiled from USDA partners and agencies throughout the US.
- Advocates / Peers
- Community Coalitions
- Community Health Officials
- Harm Reduction Specialists
- Policymakers
This report describes strategies adopted by state Medicaid programs in using data to address aspects of the opioid crisis, such as identifying outlier clinicians for opioid prescribing and patients with problematic opioid related behavior. The report describes specific programs implemented in several states.
- Cautious Opioid Prescribing
- Health Insurers
- Hospitals
- Medical
- Policymakers
This report is a part of SAMHSA's Evidence-Based Resource Guide Series. It promotes policies and practices to lower the risk of overdose for persons with opioid use disorder who are or have been in contact with criminal justice systems with a focus on medications for opioid use disorder (MOUD).
This guide:
- reviews literature and science
- examines emerging and best practices
- determines key components of peer-reviewed models that affect policies and programs
- and identifies challenges and gaps in implementation
Additionally, examples of implemented programs and links to resources are provided in this document.
- Early Intervention
- Medications for Opioid Use Disorder
- Overdose prevention
- Community Coalitions
- Community Health Officials
- Criminal Justice
- Law Enforcement
- Policymakers
This is a report from SAMHSA that examines emerging and best practices for initiating medications for opioid use disorder in emergency departments. It also reviews the existing literature and science of the topic, identifies gaps in knowledge, highlights successful program models, and discusses challenges of implementation.
- Medications for Opioid Use Disorder
- Post-overdose response
- Community Health Officials
- Health Insurers
- Hospitals
- Medical
This is an academic paper that gives a balanced policy analysis of the impact of the decriminalization of illicit drug use in Portugal. A wide array of outcomes are assessed in this drug policy reform.
- Diversion
- Educational
- Community Coalitions
- Community Health Officials
- Harm Reduction Specialists
- Law Enforcement
- Policymakers
Using National Vital Statistics System mortality data (2002-2004 and 2014-2016), this study examined associations of county-level demographic, socioeconomic, and labor market characteristics on overall drug mortality rates and specific classes of opioid mortality.
This is a white paper from the National Governors Association that discusses the history of how states have used emergency powers to provide governors with new avenues to enhance capabilities, coordination, and collaboration across state and local agencies. Guidance is provided to state officials on how to maximize this tool.
- Crisis intervention
- Educational
- Community Coalitions
- Community Health Officials
- Policymakers
This is a toolkit for state Medicaid officials on using Medicaid to advance evidence-based treatment for substance use disorders including how states may monitor and evaluate their selected strategies. Other state strategies are highlighted.
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Community Coalitions
- Community Health Officials
- Health Insurers
- Hospitals
- Medical
- Policymakers
This is a report from the Office of the Assistant Secretary of Planning and Evaluation (ASPE) that explores how telehealth can be used to support behavioral health and substance use disorders, with a particular focus on implications for medications for opioid use disorders. The report will help the reader better understand telehealth implementation and use, financing and sustainability, and impact in the field.
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Community Coalitions
- Community Health Officials
- Health Insurers
- Hospitals
- Medical
- Policymakers
This issue brief from the Office of Assistant Secretary for Planning and Evaluation (ASPE) identifies barriers to implementing buprenorphine prescribing via telehealth and makes suggestions on how to overcome these barriers. An overview of reimbursement by payors and additional links to resources are also provided in this document.
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Community Health Officials
- Health Insurers
- Hospitals
- Medical
- Policymakers
This is an academic paper that provides commentary on leveraging telehealth in rural areas to increase the capacity of medications for opioid use disorder (MOUD) in an underserved area. Current evidence for telehealth-delivered MOUD, promising program models, and regulatory issues are discussed, with links to many resources and data.
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Community Coalitions
- Community Health Officials
- Hospitals
- Medical
- Policymakers